Perspective: The Challenge for ALS Targeted Therapies Isn't Scientific Hurdles. It's the 'Valley of Death'

Perspective: The Challenge for ALS Targeted Therapies Isn’t Scientific Hurdles. It’s the ‘Valley of Death’